Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

COVID vaccine booster in pregnancy: does it protect baby too?

NCT ID NCT05543993

First seen Dec 18, 2025

Summary

This completed study followed 150 pregnant or breastfeeding women who received a bivalent COVID-19 booster. Researchers measured antibody levels in mothers, infants, and breast milk to understand how vaccination impacts immunity against COVID-19 variants. The goal was to learn more about protection for both mother and child.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania, 19107, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Bivalent COVID-19 Booster (Pfizer or Moderna)

What this could lead to

If successful, this study could help clarify how well COVID-19 vaccines protect both mothers and their babies.

What could go wrong

This is an observational study, not a treatment trial. Results may not apply to all populations or newer virus variants.

Conditions

The condition(s) this trial relates to.

Breast Feeding COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.